BIOLOGICAL · Unmapped registry intervention
177Lu-DOTA-TLX591
Find medicine records ·
Find other trials using this name
Clinical trial
External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)
NCT05146973
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedExternal Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
177Lu-DOTA-TLX591BIOLOGICAL
Sponsors & collaborators
Telix Pharmaceuticals (Innovations) Pty Limitedlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05146973 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.